MedPath

Homeopathic treatment of thyroid disorders in children and adults

Phase 2
Conditions
Health Condition 1: E039- Hypothyroidism, unspecified
Registration Number
CTRI/2023/04/051311
Lead Sponsor
D N De Homoeopathic Medical College Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patients suffering from hypothyroidism [ICD â??E03.9], newly diagnosed cases with serum TSH more than 10 µIU/ml), confirmed by biochemical tests

2) Age between 10 and 65 years

3) Patients of either sex or transgender

4) Providing with written informed consent and/or assent

5) Illiterate people will be interviewed by the investigators maintaining adequate privacy to fill up the scales or questionnaire.

Exclusion Criteria

1. Patients suffering from congenital hypothyroidism, subclinical hypothyroidism .

2. Vulnerable population - Unconscious, non-ambulatory, too sick for consultation, disabled, terminally ill or critically ill patients, mentally incompetent people

3. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure.

4.Pregnant and puerperal women, lactating mothers

5. Patients with the habit of tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence.

6.Self-reported immune-compromised state

7.Already undergoing homeopathic treatment for chronic disease within last 6 months.

8. Simultaneous participation in any other clinical trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Zulewski clinical scoreTimepoint: Baseline, every month, up to 3 months
Secondary Outcome Measures
NameTimeMethod
Serum TSH, T3, and T4Timepoint: Baseline and after 3 months;Thyroid specific patient reported outcomesTimepoint: Baseline, every month, up to 3 months
© Copyright 2025. All Rights Reserved by MedPath